Insider · CIK 0001714080

Arjona Ferreira Juan Camilo

Reports to the SEC for 2 companies · JERSEY CITY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001714080

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-11	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+11.5K sh	—	—	0
2026-08-11	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−4,134 sh	$13.62	−$56.3K	37,432.477
2026-08-11	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+11.5K sh	—	—	41,566.477
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Head of R&D & CMO	AAward	+200K sh	—	—	200,333
2026-03-31	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−4,820 sh	$5.70	−$27.5K	30,047.477
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	−13.4K sh	—	—	26,864
2026-03-31	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+13.4K sh	—	—	34,867.477
2026-03-29	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−3,181 sh	$5.84	−$18.6K	21,436.477
2026-03-29	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	−8,865 sh	—	—	8,865
2026-03-29	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+8,865 sh	—	—	23,909.355
2025-11-07	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	−6,446 sh	—	—	6,447
2025-11-07	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−2,307 sh	$6.71	−$15.5K	28,916.355
2025-11-07	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+6,446 sh	—	—	31,223.355
2025-08-11	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−4,122 sh	$9.22	−$38K	24,777.355
2025-08-11	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	−11.5K sh	—	—	11,519
2025-08-11	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+11.5K sh	—	—	28,899.355
2025-03-31	OGNOrganon & Co. · Stock Option (right to buy)A Award	Head of R&D & CMO	AAward	+198K sh	—	—	198,019
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	−8,865 sh	—	—	17,730
2025-03-31	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−3,172 sh	$14.51	−$46K	17,380.355
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+8,865 sh	—	—	20,552.355
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Head of R&D & CMO	AAward	+40.3K sh	—	—	40,295
2024-11-07	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	−6,446 sh	—	—	12,893
2024-11-07	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+6,446 sh	—	—	13,987.355
2024-11-07	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−2,300 sh	$15.80	−$36.3K	11,687.355
2024-08-11	OGNOrganon & Co.F Tax Payment	Head of R&D & CMO	FTax Payment	−3,991 sh	$20.15	−$80.4K	7,541.355
2024-08-11	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	−11.5K sh	—	—	23,038
2024-08-11	OGNOrganon & Co.M Exercise/Conversion	Head of R&D & CMO	MExercise/Conversion	+11.5K sh	—	—	11,532.355
2024-03-29	OGNOrganon & Co. · Stock Option (right to buy)A Award	Head of R&D & CMO	AAward	+109K sh	—	—	108,932
2024-03-29	OGNOrganon & Co. · Restricted Stock UnitsA Award	Head of R&D & CMO	AAward	+26.6K sh	—	—	26,595
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−134K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−65.9K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−63.7K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−155K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−160K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−86.6K sh	—	—	160,082
2023-03-10	Myovant Sciences Ltd.Performance Stock UnitD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−104K sh	—	—	0
2023-03-10	Myovant Sciences Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−79.5K sh	—	—	0
2023-01-18	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−1,109 sh	$26.89	−$29.8K	246,684
2023-01-04	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−2,251 sh	$26.90	−$60.6K	247,793
2022-10-18	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−1,604 sh	$25.20	−$40.4K	250,044
2022-10-04	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−2,738 sh	$24.40	−$66.8K	251,648
2022-07-18	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−1,606 sh	$12.87	−$20.7K	254,386
2022-07-06	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−2,755 sh	$13.40	−$36.9K	255,992
2022-05-27	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−1,382 sh	$10.07	−$13.9K	258,747
2022-04-19	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−4,632 sh	$10.45	−$48.4K	260,129
2022-04-15	Myovant Sciences Ltd.A Award	Chief Medical Officer	AAward	+104K sh	—	—	264,761
2022-04-05	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−1,922 sh	$13.78	−$26.5K	161,058
2022-03-01	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−1,362 sh	$13.35	−$18.2K	162,980
2022-01-04	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−2,271 sh	$16.27	−$36.9K	164,342
2021-11-29	Myovant Sciences Ltd.S Sale	Chief Medical Officer	SSale	−1,978 sh	$19.30	−$38.2K	166,613

Recent filings

Accepted (ET)
Aug 124
Arjona Ferreira Juan Camilo0001628280-26-056061
SEC(opens sec.gov)
Apr 24
Arjona Ferreira Juan Camilo0001628280-26-023188
SEC(opens sec.gov)
Mar 314
Arjona Ferreira Juan Camilo0001628280-26-022387
SEC(opens sec.gov)
Nov 104
Arjona Ferreira Juan Camilo0001628280-25-051052
SEC(opens sec.gov)
Aug 124
Arjona Ferreira Juan Camilo0001821825-25-000068
SEC(opens sec.gov)
Apr 24
Arjona Ferreira Juan Camilo0001821825-25-000012
SEC(opens sec.gov)

Companies

Address

C/O ORGANON &CO. 30 HUDSON STREET, FLOOR 33

JERSEY CITY, NJ, 07302